Aspirus Cancer Care - Wisconsin Rapids — Wisconsin Rapids, Wisconsin

Aspirus Cancer Care - Wisconsin Rapids is a clinical research site located in Wisconsin Rapids, Wisconsin, United States 54494.

Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.

Aspirus Cancer Care - Wisconsin Rapids has participated in 139 clinical trials with 117 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wisconsin Rapids

Browse all research sites in Wisconsin · View every site in Wisconsin Rapids

Sponsor Feasibility Report

Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aspirus Cancer Care - Wisconsin Rapids?

Aspirus Cancer Care - Wisconsin Rapids has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aspirus Cancer Care - Wisconsin Rapids conducted?

Aspirus Cancer Care - Wisconsin Rapids has 139 clinical trials on record, with 117 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Aspirus Cancer Care - Wisconsin Rapids accredited by Crixeo Clinical Trials?

Aspirus Cancer Care - Wisconsin Rapids has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aspirus Cancer Care - Wisconsin Rapids?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.